Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

$24.99

Adjustments to Financial Statements

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Adjustments to Current Assets

Medtronic PLC, adjusted current assets

US$ in millions

Microsoft Excel
Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021 Apr 24, 2020
As Reported
Current assets
Adjustments
Add: Allowances and credit losses
After Adjustment
Adjusted current assets

Based on: 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24).


The analysis of the annual financial data reveals several notable trends concerning current assets and adjusted current assets over the six-year period.

Current Assets
The value of current assets initially shows a gradual increase from $22,031 million in April 2020 to a peak of $23,059 million in April 2022. This upward trend reflects an accumulation of short-term resources during these years. However, a decline is observed in April 2023, when the figure drops to $21,675 million, followed by a slight recovery to $21,935 million in April 2024. By April 2025, current assets experience a more significant increase, reaching $23,814 million, surpassing previous levels.
Adjusted Current Assets
Adjusted current assets consistently register values slightly higher than unadjusted current assets throughout the period, indicating adjustments likely made for more accurate valuation or classification. The trend mirrors that of current assets, starting at $22,239 million in April 2020 and rising steadily to $23,289 million in April 2022. This is followed by a decrease to $21,851 million in April 2023. Subsequently, adjusted current assets increase modestly to $22,108 million in April 2024 and further improve to $24,013 million by April 2025.

Overall, the data suggest a pattern of growth in short-term asset holdings until 2022, a dip in 2023, and a rebound in 2024 and 2025. The adjustments applied to current assets maintain a consistent margin over the reported figures, implying a systematic correction process. This behavior may reflect changes in working capital management, liquidity strategies, or external economic factors impacting asset levels within the assessed periods.


Adjustments to Total Assets

Medtronic PLC, adjusted total assets

US$ in millions

Microsoft Excel
Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021 Apr 24, 2020
As Reported
Total assets
Adjustments
Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)1
Add: Allowances and credit losses
Less: Deferred tax assets2
After Adjustment
Adjusted total assets

Based on: 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24).

1 Operating lease right-of-use asset (before adoption of FASB Topic 842). See details »

2 Deferred tax assets. See details »


The annual financial data reveals the following trends regarding the asset base over the reported periods:

Total assets
The total assets have demonstrated limited variation over the six-year period. Beginning from approximately 90,689 million US dollars in April 2020, there was a slight increase in 2021 to 93,083 million. Subsequently, total assets experienced a gradual decline, reaching a low of around 89,981 million in April 2024. The final figure in April 2025 shows a modest recovery to approximately 91,680 million. Overall, the total assets exhibit a relatively stable pattern with minor fluctuations rather than significant growth or contraction.
Adjusted total assets
The adjusted total assets follow a similar trend to total assets but consistently maintain a slightly lower valuation due to adjustments. Starting at 88,115 million US dollars in April 2020, adjusted total assets increased to 90,210 million in April 2021. Thereafter, a declining trajectory is observed, with values decreasing each subsequent year to a minimum of 86,593 million in April 2024. The latest available figure for April 2025 shows a minor increase to 87,972 million. This adjusted metric mirrors the total asset trend by indicating general stability with intermittent decreases and small recoveries over the period.

In summary, both total assets and adjusted total assets have remained mostly steady with slight year-to-year variations. No significant upward or downward trends dominate the financial landscape, suggesting a period of relative asset stability with marginal declines and partial rebounds over the observed fiscal years.


Adjustments to Current Liabilities

Medtronic PLC, adjusted current liabilities

US$ in millions

Microsoft Excel
Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021 Apr 24, 2020
As Reported
Current liabilities
Adjustments
Less: Deferred revenue (included in Other accrued expenses)
After Adjustment
Adjusted current liabilities

Based on: 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24).


The financial data reveals fluctuating patterns in both current liabilities and adjusted current liabilities over the analyzed period.

Current Liabilities
The values for current liabilities demonstrate variability across the years. Starting at 10,366 million US dollars in April 2020, there is a noticeable decline to 8,509 million in April 2021. Subsequently, a sharp increase occurs in April 2022, reaching 12,394 million, followed by a reduction to 9,051 million by April 2023. The liabilities then rise again to 10,789 million in April 2024 and peak at 12,879 million in April 2025. This pattern indicates periods of both consolidation and expansion in short-term financial obligations.
Adjusted Current Liabilities
Adjusted current liabilities follow a similar trend to the unadjusted figures but consistently remain slightly lower. Beginning at 10,153 million in April 2020, there is a decrease to 8,233 million in April 2021, then an increase to 12,089 million in April 2022. A decrease follows, with the figure dropping to 8,737 million in April 2023. Afterwards, the value rises again, reaching 10,437 million in April 2024 and ultimately increasing to 12,525 million in April 2025. The adjustment appears to moderately smooth the fluctuations but maintains the overall cyclical pattern.

Overall, the data suggests an irregular cyclical pattern in the company's short-term liabilities, with notable reductions in the years 2021 and 2023, and increases after those periods. The adjusted liabilities slightly moderate the variability but do not alter the general trend. The pattern may reflect operational or strategic initiatives influencing working capital management or timing of short-term debt obligations.


Adjustments to Total Liabilities

Medtronic PLC, adjusted total liabilities

US$ in millions

Microsoft Excel
Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021 Apr 24, 2020
As Reported
Total liabilities
Adjustments
Add: Operating lease liability (before adoption of FASB Topic 842)1
Less: Deferred tax liabilities2
Less: Deferred revenue
Less: Restructuring reserve
After Adjustment
Adjusted total liabilities

Based on: 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Deferred tax liabilities. See details »


Total liabilities
The total liabilities of the company initially increased from US$39,817 million in 2020 to US$41,481 million in 2021. Subsequently, there was a decline to US$38,260 million in 2022, followed by a slight increase to US$39,283 million in 2023 and a marginal rise to US$39,561 million in 2024. The figure then saw a more pronounced increase, reaching US$43,424 million in 2025. Overall, while the liabilities fluctuated during the period, there was a notable increase toward the end of the timeline.
Adjusted total liabilities
Adjusted total liabilities mirrored the general trend observed in total liabilities, starting at US$38,228 million in 2020 and rising to US$39,939 million in 2021. There was a decrease to US$36,867 million in 2022, after which the value increased to US$37,940 million in 2023 and to US$38,446 million in 2024. The most significant increase occurred in 2025, with adjusted total liabilities reaching US$42,425 million. This pattern indicates a similar fluctuation but slightly lower values than the total liabilities throughout the period.

Adjustments to Stockholders’ Equity

Medtronic PLC, adjusted shareholders’ equity

US$ in millions

Microsoft Excel
Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021 Apr 24, 2020
As Reported
Shareholders’ equity
Adjustments
Less: Net deferred tax assets (liabilities)1
Add: Allowances and credit losses
Add: Deferred revenue
Add: Restructuring reserve
Add: Noncontrolling interests
After Adjustment
Adjusted total equity

Based on: 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24).

1 Net deferred tax assets (liabilities). See details »


Shareholders’ Equity
The shareholders’ equity experienced a general decline over the five-year period from April 24, 2020, to April 25, 2025. Starting at approximately $50.7 billion in 2020, it rose slightly in 2021 and 2022, reaching a peak of around $52.5 billion in 2022. From 2023 onwards, the equity decreased steadily, falling to about $48.0 billion by 2025. This indicates a downward trend in net asset value attributable to shareholders in recent years, potentially influenced by company-specific or market factors.
Adjusted Total Equity
The adjusted total equity followed a similar overall declining trend, beginning at roughly $49.9 billion in 2020. It increased marginally through 2021 and 2022 to just above $51.0 billion. However, from 2023, adjusted total equity consistently decreased each year, falling to approximately $45.5 billion by 2025. This decline, more pronounced than the drop in shareholders’ equity, suggests adjustments reflecting factors such as intangible assets or other valuation approaches may be impacting the reported equity base more significantly over time.
Summary of Trends
Both shareholders’ equity and adjusted total equity rose slightly in the early part of the timeframe but have demonstrated a sustained decreasing trend over the last three years. The decline in adjusted total equity is relatively sharper compared to shareholders’ equity, implying that adjusted measures capture additional elements affecting the company’s financial position. This persistent decrease in equity levels warrants attention as it may have implications for the company’s capital structure, financial flexibility, and valuation by investors.

Adjustments to Capitalization Table

Medtronic PLC, adjusted capitalization table

US$ in millions

Microsoft Excel
Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021 Apr 24, 2020
As Reported
Current debt obligations
Long-term debt
Total reported debt
Shareholders’ equity
Total reported capital
Adjustments to Debt
Add: Operating lease liability (before adoption of FASB Topic 842)1
Add: Operating lease current liability (classified in Other accrued expenses)2
Add: Operating lease non-current liability (classified in Other liabilities)3
Adjusted total debt
Adjustments to Equity
Less: Net deferred tax assets (liabilities)4
Add: Allowances and credit losses
Add: Deferred revenue
Add: Restructuring reserve
Add: Noncontrolling interests
Adjusted total equity
After Adjustment
Adjusted total capital

Based on: 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Operating lease current liability (classified in Other accrued expenses). See details »

3 Operating lease non-current liability (classified in Other liabilities). See details »

4 Net deferred tax assets (liabilities). See details »


The analysis of the provided financial data over six consecutive annual periods reveals several notable trends and shifts in the company’s capital structure.

Total Reported Debt
This figure showed a slight increase from 24,797 million USD in April 2020 to 28,516 million USD in April 2025, with minor fluctuations in the intermediate years. The debt level declined somewhat during 2021 and 2022 but then resumed an upward trend, reaching its highest point in the last reported year.
Shareholders’ Equity
Equity values demonstrated a gradual decline over the same timeframe. Starting at 50,737 million USD in April 2020, equity peaked marginally in 2022 before steadily decreasing to 48,024 million USD by April 2025. This downward trend in equity suggests a reduction in net assets supported by shareholders.
Total Reported Capital
Total reported capital remained relatively stable, fluctuating within a narrow range between approximately 75,000 million USD and 77,800 million USD. There was a slight dip after 2021 but with a moderate recovery by 2025. This stability reflects offsetting movements between debt and equity components.
Adjusted Total Debt
The adjusted debt figures closely mirror the total reported debt, increasing overall from 25,742 million USD in 2020 to 29,626 million USD in 2025. The trend confirms the company’s gradual increase in debt obligations on an adjusted basis as well, paralleling the reported debt behavior.
Adjusted Total Equity
Adjusted equity also exhibits a declining trend, falling from 49,887 million USD in 2020 to 45,547 million USD in 2025. This change is consistent with the decline observed in shareholders' equity, indicating a reduction in net capital under adjusted accounting measures.
Adjusted Total Capital
Adjusted total capital values remain quite consistent, ranging narrowly between 75,000 million USD and 77,600 million USD. While there is a slight downward trend after 2021, the capital base sustains relative stability, reflecting a balance between increases in debt and decreases in equity.

Overall, the data exhibits a clear pattern: debt levels have generally increased over the six-year period, while equity has declined correspondingly. This shift suggests a gradual increase in financial leverage. Despite these changes, the company’s total capital, both reported and adjusted, has remained comparatively stable, indicating that the overall capital structure adjusts through reciprocal movements in debt and equity rather than large swings in total capitalization.


Adjustments to Revenues

Medtronic PLC, adjusted net sales

US$ in millions

Microsoft Excel
12 months ended: Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021 Apr 24, 2020
As Reported
Net sales
Adjustment
Add: Increase (decrease) in deferred revenue
After Adjustment
Adjusted net sales

Based on: 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24).


Net Sales
The net sales figures demonstrate a consistent upward trend over the six-year period from April 2020 to April 2025. Starting at $28,913 million in 2020, the net sales increased to $33,537 million by 2025. Although growth is generally steady, there is a slight decline observed between 2022 and 2023, where net sales decreased from $31,686 million to $31,227 million, before resuming growth in subsequent years.
Adjusted Net Sales
Adjusted net sales closely follow the pattern of net sales, starting at $28,901 million in 2020 and reaching $33,530 million by 2025. The incremental changes mirror those seen in net sales, including the minor dip in 2023. The proximity of adjusted net sales to net sales throughout the periods indicates minimal adjustments affecting overall revenue recognition.
Overall Trend and Insights
Both net sales and adjusted net sales exhibit a general growth trajectory over the analyzed period, indicating positive business performance and expansion. The brief decline in 2023 could suggest temporary market challenges or operational impacts that were subsequently overcome. The stable ratio between net sales and adjusted net sales suggests consistent accounting practices and potential stability in factors requiring adjustment.

Adjustments to Reported Income

Medtronic PLC, adjusted net income attributable to Medtronic

US$ in millions

Microsoft Excel
12 months ended: Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021 Apr 24, 2020
As Reported
Net income attributable to Medtronic
Adjustments
Add: Deferred income tax expense (benefit)1
Add: Increase (decrease) in allowances and credit losses
Add: Increase (decrease) in deferred revenue
Add: Increase (decrease) in restructuring reserve
Add: Other comprehensive income (loss), net of tax
Add: Comprehensive income (loss), net of tax, attributable to noncontrolling interest
After Adjustment
Adjusted net income

Based on: 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24).

1 Deferred income tax expense (benefit). See details »


The financial data presented for the company shows fluctuations in both net income attributable to the company and adjusted net income over the periods ending from April 24, 2020, through April 25, 2025.

Net Income Attributable to the Company
Net income exhibited variability throughout the observed periods. It started at 4,789 million US dollars in April 2020, then declined significantly to 3,606 million in April 2021. This was followed by a recovery to 5,039 million in April 2022. Subsequently, net income again decreased to 3,758 million and 3,676 million in April 2023 and April 2024 respectively, before rising once more to 4,662 million in April 2025. The pattern is characterized by alternating periods of growth and contraction, indicating possible volatility in earnings or fluctuating operational performance over the years.
Adjusted Net Income
Adjusted net income also demonstrated considerable variation, though the trend does not always parallel that of the reported net income. Starting at 2,672 million US dollars in April 2020, it increased to 3,392 million in April 2021 and then showed a sharp rise to 5,642 million in April 2022, which represents the peak in the dataset. However, in the following year it dropped markedly to 2,369 million in April 2023, before partially recovering in the two subsequent years to 3,315 million and 3,414 million respectively. This suggests that items excluded from the adjusted net income calculation may significantly impact profitability, as reflected in the divergence and sharp changes seen in certain periods.
Comparative Insights
When comparing net income and adjusted net income, it is clear that adjusted net income tends to be lower than the net income attributable to the company, except in the period ending April 29, 2022, where adjusted net income exceeds the net income figure. The fluctuations in adjusted net income are more pronounced than those in net income attributable, indicating that non-recurring or special items can greatly influence the reported profitability. The data does not show a consistent trend in either measure, but both indicate periods of contraction and recovery which may be related to external economic factors, company-specific operational challenges, or adjustments in accounting practices.